Works matching AU Gurion, Ronit

Results: 56
    1
    2
    3
    4
    5
    6

    Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 1, p. 118, doi. 10.1080/10428194.2020.1824069
    By:
    • Segman, Yafit;
    • Ribakovsky, Elena;
    • Avigdor, Abraham;
    • Goldhecht, Yair;
    • Vainstein, Vladimir;
    • Goldschmidt, Neta;
    • Harlev, Shimrit;
    • Horwitz, Netanel;
    • Gutwein, Odit;
    • Gurion, Ronit;
    • Itchaki, Gilad;
    • Abadi, Uri;
    • Nemets, Anatoly;
    • Sofer, Orit;
    • Zektser, Miri;
    • Tadmor, Tamar;
    • Dally, Nagib;
    • Filanovsky, Kalman;
    • Leiba, Merav;
    • Sarid, Nadav
    Publication type:
    Article
    7
    8
    9

    Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 5, p. 1163, doi. 10.1080/10428194.2017.1375102
    By:
    • Bentur, Ohad S.;
    • Sarid, Nadav;
    • Ram, Ron;
    • Herishanu, Yair;
    • Avivi, Irit;
    • Perry, Chava;
    • Kreiniz, Natalia;
    • Dally, Najib;
    • Gurion, Ronit;
    • Raanani, Pia;
    • Gafter-Gvili, Anat;
    • Gutwein, Odit;
    • Gatt, Moshe;
    • Paltiel, Ora;
    • Shvidel, Lev;
    • Ganzel, Chezi;
    • Horowitz, Netanel A.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 483, doi. 10.1016/j.clml.2021.12.016
    By:
    • Schuster, Michael;
    • Zijlstra, Josée;
    • Casasnovas, Rene-Olivier;
    • Vermaat, Joost S. P.;
    • Kalakonda, Nagesh;
    • Goy, Andre;
    • Choquet, Sylvain;
    • Neste, Eric Van Den;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • Cruz, Fatima De la;
    • Kuruvilla, John;
    • Hamad, Nad;
    • Jaeger, Ulrich;
    • Caimi, Paolo;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer;
    • Sancho, Juan-Manuel
    Publication type:
    Article
    20

    Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
    By:
    • Casasnovas, Rene-Olivier;
    • Follows, George;
    • Zijlstra, Josee M.;
    • Vermaat, Joost S.P.;
    • Kalakonda, Nagesh;
    • Choquet, Sylvain;
    • Van Den Neste, Eric;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • De la Cruz, Fatima;
    • Kuruvilla, John;
    • Hamad, Nada;
    • Jaeger, Ulrich;
    • Caimi, Paolo F.;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer;
    • Sancho, Juan-Manuel;
    • Schuster, Michael
    Publication type:
    Article
    21
    22
    23
    24
    25

    A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S248, doi. 10.1016/j.clml.2019.07.153
    By:
    • Kalakonda, Nagesh;
    • Cavallo, Federica;
    • Follows, George;
    • Goy, Andre;
    • Vermaat, Joost S.P.;
    • Casasnovas, Olivier;
    • Lavee, Orly;
    • Maerevoet, Marie;
    • Zijlstra, Josée;
    • Bakhshi, Sameer;
    • Bouabdallah, Reda;
    • Choquet, Sylvain;
    • Gurion, Ronit;
    • Hill, Brian;
    • Jaeger, Ulrich;
    • Sancho, Juan-Manuel;
    • Schuster, Michael;
    • Thieblemont, Catherine;
    • De la Cruz, Fatima;
    • Egyed, Miklós
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.

    Published in:
    2021
    By:
    • Maerevoet, Marie;
    • Zijlstra, Josee M.;
    • Follows, George;
    • Casasnovas, Rene-Olivier;
    • Vermaat, J. S. P.;
    • Kalakonda, Nagesh;
    • Goy, Andre;
    • Choquet, Sylvain;
    • Van Den Neste, Eric;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • De la Cruz, Fatima;
    • Kuruvilla, John;
    • Hamad, Nada;
    • Jaeger, Ulrich;
    • Caimi, Paolo;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer
    Publication type:
    Letter
    32
    33
    34
    35
    36
    37

    Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
    By:
    • Vassilakopoulos, Theodoros P.;
    • Panitsas, Fotios;
    • Mellios, Zois;
    • Apostolidis, John;
    • Michael, Michalis;
    • Gurion, Ronit;
    • Ferhanoglu, Burhan;
    • Hatzimichael, Eleftheria;
    • Karakatsanis, Stamatios;
    • Dimou, Maria;
    • Kalpadakis, Christina;
    • Katodritou, Eirini;
    • Leonidopoulou, Theoni;
    • Kotsianidis, Ioannis;
    • Giatra, Hara;
    • Kanellias, Nick;
    • Sayyed, Ayman;
    • Tadmor, Tamar;
    • Akay, Olga Meltem;
    • Angelopoulou, Maria K.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45

    The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study.

    Published in:
    European Journal of Haematology, 2023, v. 110, n. 2, p. 149, doi. 10.1111/ejh.13884
    By:
    • Shargian, Liat;
    • Amit, Odelia;
    • Bernstine, Hanna;
    • Gurion, Ronit;
    • Gafter‐Gvili, Anat;
    • Rozovski, Uri;
    • Pasvolsky, Oren;
    • Perets, Galit;
    • Horowitz, Netanel A.;
    • Halloun, Jabour;
    • Perry, Chava;
    • Avivi, Irit;
    • Raanani, Pia;
    • Yeshurun, Moshe;
    • Ram, Ron
    Publication type:
    Article
    46
    47
    48
    49
    50